Austar Lifesciences Limited
AULSF
$0.07
$0.071,300.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 325.97% | 319.86% | 113.93% | 114.04% | 114.24% |
| Total Depreciation and Amortization | -1.26% | -2.69% | 9.61% | 10.48% | 29.85% |
| Total Amortization of Deferred Charges | 13.64% | 12.01% | 6.14% | 7.01% | -1.20% |
| Total Other Non-Cash Items | 2.03% | 3.44% | -90.45% | -90.37% | 74.78% |
| Change in Net Operating Assets | -- | -- | 119.29% | 119.44% | -- |
| Cash from Operations | 99.72% | 96.84% | 3,548.74% | 3,576.10% | 129.16% |
| Capital Expenditure | -102.54% | -99.64% | 56.86% | 56.52% | 84.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -19,524.32% | -19,621.62% | -61.88% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.14% | -52.83% | 159.67% | 161.73% | 93.00% |
| Cash from Investing | -122.35% | -122.03% | 72.68% | 72.46% | 147.11% |
| Total Debt Issued | 11.50% | 11.50% | -29.03% | -29.03% | -34.06% |
| Total Debt Repaid | -0.40% | -0.40% | -27.71% | -27.71% | -62.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.46% | 25.46% | -9.66% | -9.66% | 44.68% |
| Cash from Financing | 31.69% | 32.67% | -170.25% | -170.81% | -165.79% |
| Foreign Exchange rate Adjustments | -143.53% | -142.74% | 1,520.59% | 1,526.47% | 251.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.98% | 91.11% | -28.92% | -28.35% | -197.59% |